When:
Friday, June 2, 2023 - 12:00am
An initiative research collabortion with academic researchers to advance the most innovative discoveries for therapeutic targets, pathways, and techologies.
- $125,000 research funding for 12 months
- Potential opportunity to convert projects to sponsored research programs
- Areas of interest: Antibody-drugconjugate (ADC) resistance, novelcell-surface E3 ligases or glycanreceptors, preclinical models torecapitulate cancer biology